The Heterogeneity of Amyotrophic Lateral Sclerosis: A Possible Explanation of Treatment Failure

E-ISSN： 1875-533x|14|30|3185-3200

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.14, Iss.30, 2007-12, pp. : 3185-3200

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The tolerability of riluzole in the treatment of patients with amyotrophic lateral sclerosis

By Bensimon Gilbert Doble Adam

Expert Opinion on Drug Safety, Vol. 3, Iss. 6, 2004-11 ,pp. : 525-534

Informa Healthcare

Access to resources Recommend Favorite

Amyotrophic Lateral Sclerosis: Progress and Prospects for Treatment

By Dib M.

Drugs, Vol. 63, Iss. 3, 2003-01 ,pp. : 289-310

Adis International

Access to resources Recommend Favorite

Therapeutic developments in the treatment of amyotrophic lateral sclerosis

By Jackson Mandy Lladó Jerònia Rothstein Jeffrey D

Expert Opinion on Investigational Drugs, Vol. 11, Iss. 10, 2002-10 ,pp. : 1343-1364

Informa Healthcare

Access to resources Recommend Favorite

Targeting Astrocytes for Treatment in Amyotrophic Lateral Sclerosis

Current Pharmaceutical Design, Vol. 23, Iss. 33, 2018-01 ,pp. : 5037-5044

Bentham Science Publishers

Access to resources Recommend Favorite

Management of Amyotrophic Lateral Sclerosis

By Corcia Philippe Meininger Vincent

Drugs, Vol. 68, Iss. 8, 2008-01 ,pp. : 1037-1048

Adis International

Access to resources Recommend Favorite